Skip to main content

. 1982 Oct 9;285(6347):1009. doi: 10.1136/bmj.285.6347.1009

Severe headache and disturbed liver function during treatment with zimelidine.

J M Sommerville, E H McLaren, L M Campbell, J M Watson

PMCID: PMC1500311 PMID: 6215083

1009

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Coppen A., Ramo Rao V. A., Swade C., Wood K. Zimelidine: a therapeutic and pharmacokinetic study in depression. Psychopharmacology (Berl) 1979 Jun 21;63(3):199–202. doi: 10.1007/BF00433549. [DOI] [PubMed] [Google Scholar]
Ross S. B., Jansa S., Wetterberg L., Fyrö B., Hellner B. Decreased blood level of 5-dehydroxytryptamine by inhibitors of the membranal 5-hydroxytryptamine uptake. Life Sci. 1976 Jul 15;19(2):205–210. doi: 10.1016/0024-3205(76)90391-x. [DOI] [PubMed] [Google Scholar]
Siwers B., Ringberger V. A., Tuck J. R., Sjöqvist F. Initial clinical trial based on biochemical methodology of zimelidine (a serotonin uptake inhibitor) in depressed patients. Clin Pharmacol Ther. 1977 Feb;21(2):194–200. doi: 10.1002/cpt1977212194. [DOI] [PubMed] [Google Scholar]
Somerville B. W. Platelet-bound and free serotonin levels in jugular and forearm venous blood during migraine. Neurology. 1976 Jan;26(1):41–45. doi: 10.1212/wnl.26.1.41. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES